Robeco Institutional Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-40,547
| Closed | -$167K | – | 964 |
|
|
2024
Q1 | $167K | Hold |
40,547
| – | – | ﹤0.01% | 914 |
|
|
2023
Q4 | $171K | Sell |
40,547
-9,003
| -18% | -$38K | ﹤0.01% | 917 |
|
|
2023
Q3 | $214K | Hold |
49,550
| – | – | ﹤0.01% | 918 |
|
|
2023
Q2 | $327K | Hold |
49,550
| – | – | ﹤0.01% | 897 |
|
|
2023
Q1 | $336K | Hold |
49,550
| – | – | ﹤0.01% | 884 |
|
|
2022
Q4 | $366K | Buy |
49,550
+19,256
| +64% | +$142K | ﹤0.01% | 873 |
|
|
2022
Q3 | $300K | Buy |
30,294
+24,245
| +401% | +$240K | ﹤0.01% | 803 |
|
|
2022
Q2 | $66K | Hold |
6,049
| – | – | ﹤0.01% | 888 |
|
|
2022
Q1 | $68K | Hold |
6,049
| – | – | ﹤0.01% | 893 |
|
|
2021
Q4 | $95K | Sell |
6,049
-19,856
| -77% | -$312K | ﹤0.01% | 868 |
|
|
2021
Q3 | $444K | Buy |
+25,905
| New | +$444K | ﹤0.01% | 782 |
|